C07C 311/54
Either x or y, but not both, being nitrogen atoms
Official title: either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
C07C311/54 (Either x or y, but not both, being nitrogen atoms) appears on 227 US grants and 142 published applications in this corpus.
Search patents in C07C- Granted patents
- 227
- Published applications
- 142
- Assignees
- 118
- Inventors
- 495
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 6 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 10 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 1 |
| 2002 | 21 | 12 |
| 2003 | 9 | 18 |
| 2004 | 18 | 10 |
| 2005 | 6 | 7 |
| 2006 | 1 | 6 |
| 2007 | 4 | 4 |
| 2008 | 6 | 5 |
| 2009 | 2 | 2 |
| 2010 | 2 | 3 |
| 2011 | 1 | 2 |
| 2012 | 2 | 2 |
| 2013 | 5 | 2 |
| 2014 | 0 | 2 |
| 2015 | 4 | 5 |
| 2016 | 2 | 5 |
| 2017 | 5 | 7 |
| 2018 | 3 | 3 |
| 2019 | 5 | 2 |
| 2020 | 1 | 5 |
| 2021 | 3 | 9 |
| 2022 | 2 | 7 |
| 2023 | 7 | 9 |
| 2024 | 5 | 6 |
| 2025 | 3 | 4 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Subtituted sulfonylurea and sulfoximineurea derivatives14 Apr 2026US 12,599,616 B2Zydus Lifesciences Limited
- Probenecid compounds for the treatment of inflammasome-mediated lung disease17 Mar 2026US 12,577,211 B2Bacainn Biotherapeutics, Ltd.
- Sulfonylurea derivative and medical uses thereof9 Dec 2025US 12,492,166 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- NLRP3 modulators8 Jul 2025US 12,351,564 B2Zomagen Biosciences Ltd
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Probenecid compounds for the treatment of inflammasome-mediated dermatological conditions25 Jun 2026US 2026/0176232 A1Bacainn Biotherapeutics, Ltd.
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- Protoporphyrinogen oxidase inhibitors12 Mar 2026US 2026/0068883 A1Enko Chem, Inc.
- Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereof5 Jun 2025US 2025/0179000 A1Sanford Burnham Prebys Medical Discovery Institute
Most cited
By later US patents
- 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds79US 6,818,634 B2Paratek Pharmaceuticals, Inc. · 2004
- Benzoyl-substituted phenylalanineamides74US 7,687,435 B2BASF SE · 2010
- 13-substituted methacycline compounds59US 6,500,812 B2Paratek Pharmaceuticals, Inc. · 2002
- Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines56US 5,424,333 ARohm and Haas Company · 1995
- Substituted phenyl derivatives, their preparation and use47US 6,297,261 B1NeuroSearch A/S · 2001